CIFLORPAN and Unigen will work side by side to collect plants that have documented ethnomedical uses by native tribes. This research will identify lead compounds for the development of pharmaceutical, nutraceutical, cosmeceutical and functional food products. Unigen will apply natural product chemistry and high throughput screening to fractionate the Panamanian plant extracts, which will be further tested in its laboratory, executives said.
“Panama is among the top 25 most plant-rich countries in the world, with rainforests that provide a perfect level of light intensity, humidity and temperature to yield unique and diverse plants containing the most biodiversity and high nutrient content,” said Dr. Qi Jia, vice president of scientific affairs, Unigen.
Dr. Mahabir Gupta, principal investigator and director of CIFLORPAN, said, “Our scientific team is excited about the opportunity to share knowledge and collaborate with Unigen on a project designed to create novel and indigenous products addressing the health needs of the world.”